Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghaith Bakdash

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|August 11, 2015
Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonistsMartin Kreutz, Ghaith Bakdash, Yusuf Dolen, et al.
Bio-Protocol|September 20, 2021
Isolation of Mononuclear Cell Populations from Ovarian Carcinoma AscitesChristina Wefers, Ghaith Bakdash, Meritxell Mereno Martin, et al.
Vaccines|September 22, 2018
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?Thomas J van Ee, Heleen H Van Acker, Tom G van Oorschot, et al.
Oncoimmunology|November 18, 2016
Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicityJasper J P van Beek, Mark A J Gorris, Annette E Sköld, et al.
Oncotarget|February 11, 2017
Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapyTill S M Mathan, Johannes Textor, Annette E Sköld, et al.
Cell Reports. Medicine|January 19, 2024
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potentialAnouk M D Becker, Annika H Decker, Georgina Flórez-Grau, et al.
Cancer Immunology, Immunotherapy : CII|July 19, 2018
Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cellsAnnette E Sköld, Till S M Mathan, Jasper J P van Beek, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2011
Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cellsAngelic M G van der Aar, Darya S Sibiryak, Ghaith Bakdash, et al.
Iscience|July 21, 2025
Interleukin-6 in synovial fluid drives the conversion of DC2s to DC3s in inflammatory arthritisAnnika H Decker, Lucas L van den Hoogen, Tom van Oorschot, et al.
Cancer Research|June 22, 2016
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell VaccinesGhaith Bakdash, Sonja I Buschow, Mark A J Gorris, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|August 11, 2015
Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonistsMartin Kreutz, Ghaith Bakdash, Yusuf Dolen, et al.
Bio-Protocol|September 20, 2021
Isolation of Mononuclear Cell Populations from Ovarian Carcinoma AscitesChristina Wefers, Ghaith Bakdash, Meritxell Mereno Martin, et al.
Vaccines|September 22, 2018
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?Thomas J van Ee, Heleen H Van Acker, Tom G van Oorschot, et al.
Oncoimmunology|November 18, 2016
Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicityJasper J P van Beek, Mark A J Gorris, Annette E Sköld, et al.
Oncotarget|February 11, 2017
Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapyTill S M Mathan, Johannes Textor, Annette E Sköld, et al.
Cell Reports. Medicine|January 19, 2024
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potentialAnouk M D Becker, Annika H Decker, Georgina Flórez-Grau, et al.
Cancer Immunology, Immunotherapy : CII|July 19, 2018
Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cellsAnnette E Sköld, Till S M Mathan, Jasper J P van Beek, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2011
Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cellsAngelic M G van der Aar, Darya S Sibiryak, Ghaith Bakdash, et al.
Iscience|July 21, 2025
Interleukin-6 in synovial fluid drives the conversion of DC2s to DC3s in inflammatory arthritisAnnika H Decker, Lucas L van den Hoogen, Tom van Oorschot, et al.
Cancer Research|June 22, 2016
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell VaccinesGhaith Bakdash, Sonja I Buschow, Mark A J Gorris, et al.
Pageof 3